Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | KPL Kwality Pharmaceuticals Limited Pharma · Small | VENUSREM Venus Remedies Limited Pharma · Small | MOREPENLAB Morepen Laboratories Limited Pharma · Small | UNICHEMLAB Unichem Laboratories Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 55 | 60 | 27 | 69 |
| Verdict | FAIR VALUE | UNDERVALUED | OVERVALUED | UNDERVALUED |
| Style | Premium Compounder | Growth at Value | OVERVALUED | Deep Value |
| Piotroski | 8/9 | 7/9 | 7/9 | 8/9 |
| Valuation | 4/30 | 13/30 | 5/30 | 27/30 |
| Growth | 18/25 | 18/25 | 4/25 | 18/25 |
| Quality | 16/20 | 13/20 | 0/20 | 0/20 |
| Balance Sheet | 9/15 | 8/15 | 9/15 | 11/15 |
| Cash Flow | 4/10 | 4/10 | 4/10 | 8/10 |
| Price | ₹2,338.6 | ₹1,610.7 | ₹48.65 | ₹379.65 |
| P/E | 34.70 | 22.00 | 31.60 | 32.10 |
| P/B | 7.10 | 3.41 | 1.88 | 0.92 |
| ROE | 22.80% | 16.80% | 6.20% | 3.03% |
| ROCE | 24.20% | 21.70% | 8.05% | 3.99% |
| Debt / Equity | 0.39 | 0.02 | 0.17 | 0.18 |
| FCF Yield | — | — | — | 7.80% |
| Dividend Y | — | — | 0.47% | — |
| Altman Z | 7.88 | 8.81 | 5.05 | 3.50 |
| Promoter % | 54.87% | 41.76% | 35.66% | 70.22% |
| Mkt Cap (₹Cr) | 2356.00 | 2266.00 | 2349.00 | 2513.00 |
| Graham # | ₹683.63 | ₹927.33 | ₹29.79 | ₹558.46 |
| Fair PE | 42.0 | 42.0 | 5.4 | 42.0 |
| MoS % | +14.2% | +50.1% | -420.7% | +74.8% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startKPL144
VENUSREM508
MOREPENLAB58
UNICHEMLAB42